| Tamara Sue Bach, FNP-BC | |
|
195 Feather Way Ste 100, Evanston, WY 82930-9352 | |
| (307) 200-9200 | |
| (307) 200-4808 |
| Full Name | Tamara Sue Bach |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 8 Years |
| Location | 195 Feather Way Ste 100, Evanston, Wyoming |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346745205 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SF0001X | Clinical Nurse Specialist - Family Health | 22296.1641 (Wyoming) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Evanston Regional Hospital | Evanston, WY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sterling Provider Group | 2264773373 | 50 |
News Archive
A research team from Keele University's Institute for Primary Care and Health Sciences has been awarded a major grant of £2.4 million from the National Institute for Health Research to investigate the overprescribing of opioid painkillers, and to improve care for patients with persistent pain - without the use of long-term opioids.
Taking a biopsy of a brain tumor is a complicated and invasive surgical process, but a team of researchers at Washington University in St. Louis is developing a way that allows them to detect tumor biomarkers through a simple blood test.
Infinity Pharmaceuticals, Inc. today announced that Purdue Pharmaceutical Products L.P. and its independent associated company, Mundipharma International Corporation Ltd., have exercised their right to assume worldwide development and commercialization activities for Infinity's fatty acid amide hydrolase, or FAAH, program. The decision reflects progress made in the development of Infinity's oral FAAH inhibitor, IPI-940.
Research completed in NUI Galway has shown that lowering blood pressure by taking blood pressure medications reduces the risk of developing dementia and cognitive impairment by 7%.
› Verified 7 days ago
| Entity Name | South Lincoln Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033221569 PECOS PAC ID: 2961490057 Enrollment ID: O20040604000832 |
News Archive
A research team from Keele University's Institute for Primary Care and Health Sciences has been awarded a major grant of £2.4 million from the National Institute for Health Research to investigate the overprescribing of opioid painkillers, and to improve care for patients with persistent pain - without the use of long-term opioids.
Taking a biopsy of a brain tumor is a complicated and invasive surgical process, but a team of researchers at Washington University in St. Louis is developing a way that allows them to detect tumor biomarkers through a simple blood test.
Infinity Pharmaceuticals, Inc. today announced that Purdue Pharmaceutical Products L.P. and its independent associated company, Mundipharma International Corporation Ltd., have exercised their right to assume worldwide development and commercialization activities for Infinity's fatty acid amide hydrolase, or FAAH, program. The decision reflects progress made in the development of Infinity's oral FAAH inhibitor, IPI-940.
Research completed in NUI Galway has shown that lowering blood pressure by taking blood pressure medications reduces the risk of developing dementia and cognitive impairment by 7%.
› Verified 7 days ago
| Entity Name | Sterling Provider Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205300407 PECOS PAC ID: 2264773373 Enrollment ID: O20190417002023 |
News Archive
A research team from Keele University's Institute for Primary Care and Health Sciences has been awarded a major grant of £2.4 million from the National Institute for Health Research to investigate the overprescribing of opioid painkillers, and to improve care for patients with persistent pain - without the use of long-term opioids.
Taking a biopsy of a brain tumor is a complicated and invasive surgical process, but a team of researchers at Washington University in St. Louis is developing a way that allows them to detect tumor biomarkers through a simple blood test.
Infinity Pharmaceuticals, Inc. today announced that Purdue Pharmaceutical Products L.P. and its independent associated company, Mundipharma International Corporation Ltd., have exercised their right to assume worldwide development and commercialization activities for Infinity's fatty acid amide hydrolase, or FAAH, program. The decision reflects progress made in the development of Infinity's oral FAAH inhibitor, IPI-940.
Research completed in NUI Galway has shown that lowering blood pressure by taking blood pressure medications reduces the risk of developing dementia and cognitive impairment by 7%.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tamara Sue Bach, FNP-BC 195 Feather Way Ste 100, Evanston, WY 82930-9352 Ph: (307) 200-9200 | Tamara Sue Bach, FNP-BC 195 Feather Way Ste 100, Evanston, WY 82930-9352 Ph: (307) 200-9200 |
News Archive
A research team from Keele University's Institute for Primary Care and Health Sciences has been awarded a major grant of £2.4 million from the National Institute for Health Research to investigate the overprescribing of opioid painkillers, and to improve care for patients with persistent pain - without the use of long-term opioids.
Taking a biopsy of a brain tumor is a complicated and invasive surgical process, but a team of researchers at Washington University in St. Louis is developing a way that allows them to detect tumor biomarkers through a simple blood test.
Infinity Pharmaceuticals, Inc. today announced that Purdue Pharmaceutical Products L.P. and its independent associated company, Mundipharma International Corporation Ltd., have exercised their right to assume worldwide development and commercialization activities for Infinity's fatty acid amide hydrolase, or FAAH, program. The decision reflects progress made in the development of Infinity's oral FAAH inhibitor, IPI-940.
Research completed in NUI Galway has shown that lowering blood pressure by taking blood pressure medications reduces the risk of developing dementia and cognitive impairment by 7%.
› Verified 7 days ago
James Patrick Fleenor, ANP Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 831 Highway 150 S, Evanston, WY 82930 Phone: 307-789-3464 Fax: 307-789-7373 | |
Mr. Eric G Roman, NP Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 831 Highway 150 S, Evanston, WY 82930 Phone: 307-789-3464 Fax: 307-789-7373 | |
Marisha Lee Vanvleet, APRN-CNP, PMHNP-BC Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 724 Front St Ste 404, Evanston, WY 82930 Phone: 307-288-2328 Fax: 307-448-4606 |